In vivo, reduced KIF2C expression led to a significant reduction in tumor volume and weight in mice, while overexpression of KIF2C promoted malignant proliferation and inhibited apoptosis in OS, highlighting the role of KIF2C in the malignant progression of OS. Here, KIF2C is linked to neoplasm.